Field Medical Director (MSL) – Ophthalmology (Southeast Region)
Annexon Biosciences
| Company | Annexon Biosciences |
| Category | Healthcare |
| Location | San Francisco Bay Area |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 24 Jul 2026 |
| Last verified | 11 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
Company:
At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.
For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline . We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.
We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture !
Position:
The Field Medical Directors (FMDs) are medical experts who are an extension of the Medical Affairs team and represent Annexon with key stakeholders. They engage with national, regional, and local scientific, clinical, and social thought leaders (TLs) at academic and community medical centers as the scientific and medical expert on Annexon’s products and areas of research. This role will develop and maintain professional relationships with TLs based on scientific exchange of disease and Annexon product data.
Responsibilities include:
Develop and maintain professional relationships with Thought Leaders (TLs) through compliant scientific exchange via two-way communication inclusive but not limited to pathogenesis of Therapeutic Areas (TA) of interest to Annexon, diagnosis, disease burden, treatment landscape, health economics, and relevant Annexon product data in line with medical affairs and Annexon strategy
Collaborate with TLs on research projects, national and regional advisory boards, visiting professorships, publications, and peer-to-peer educational initiatives
Develop and maintain the highest scientific and medical expertise in ophthalmologic disease, trials and treatment landscape with a patient centric mindset
Identify potential high-impact medical research projects, investigator-initiated research, health-economic trials, and publication opportunities in line with Annexon TAs of interest
Be acknowledged internally and externally as a trusted Scientific expert and build lasting professional relationships with TLs and Centers of Excellence & Research (COERs)
Attend local, regional, national, international meetings and congresses as needed to engage in Scientific exchange, capture scientific insights, share data on Annexon products and TAs, and identify areas for collaboration with TLs
Respond to healthcare professionals (HCPs) with integrity, a sense of urgency, adherence to all laws, regulations, and Annexon guidelines, policies & procedures
Partner with Patient Advocacy Organizations in a compliant manner to integrate the patient voice into scientific and medical communications
Deliver education on Annexon’s science and product data to P&T committees, formulary decision makers, and local, regional and national payers in accordance with all laws, regulations, and Annexon’s guidelines, policies, and p